Dr. Derek Petry named CEO of Choice Genetics USA
After two-year stint in vice presidential role, Derek Petry appointed CEO
Dr. Derek Petry has been named CEO of Choice Genetics USA (CGUSA). Based in West Des Moines, Iowa, Petry has worked in the swine industry for over 10 years, joining CGUSA in 2012, as vice of president of research and development.
Dr. Petry began his career with Monsanto Choice Genetics where he led commercial breeding value implementation and benchmarking. Before joining CGUSA he worked with Triumph Foods in St. Joseph, Missouri as the technical leader of the company‟s research and food quality/safety programs.
Dr. Petry earned a bachelor of science degree from Texas A&M University majoring in poultry science.
At the University of Nebraska-Lincoln, he earned an MBA as well as a master's degree and Ph.D. in animal science focusing in quantitative and molecular genetics with a minor in statistics. Petry also holds a Master‟s Degree in food science from Kansas State University.
In his new role, Petry will focus on driving innovation in Choice Genetics‟ global R&D platform and on delivering value to customers. Other managers of CGUSA include Brent Mitchell, COO, George Lindsey, CFO, Kris Kercher, VP of Administration and Logistics and Jim Schirmer, Director of Business Development - Asia.
“During the two years since Derek joined us he has proven to have that rare combination of skills: a deep theoretical understanding of the complex science of genetics and a sense for ‘hands-on’ implementation in the field. This is what we need in our world of applied animal genetics. This approach translated itself into faster genetic progress for our customers. I’m convinced Derek will show the same drive in his new role as CEO of CGUSA,” said Pieter Seghers, CEO of Choice Genetics worldwide.
"I am honored that Choice Genetics and Groupe Grimaud management have entrusted me to lead the USA organization. This is an exciting time for our business as we have taken on a new global strategic partner. It's a moment of transition when, more than ever before, we have the opportunity to help customers by delivering value through superior genetics and maximizing progress for them,” said Petry.